MetaCap

Orchestra BioMed Statistics

NASDAQ: OBIOHealth Care Medicinal Chemicals and Botanical Products USD

6.58-0.42 (-6.00%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Orchestra BioMed by the numbers

Orchestra BioMed has a market capitalization of $517.9 million based on 78.70M shares outstanding. With trailing EPS of $-0.75, Orchestra BioMed is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.5% above its 50-day average and 39.7% above its 200-day average.

Average daily trading volume is 420.19K shares, or about $2.8 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

OBIO valuation vs. peer median

OBIO compared with the median of 8 peer companies
MetricOBIOPeer medianDifference
Market cap$517.88M$217.40M+138%
Avg. volume420.19K1.29M-67%

Peer median across 8 companies: SNDL, TLRY, ACB, USNA, MDWD, CGC, NAGE, GLAS.

Valuation

Market cap
$517.88M
Price / sales (latest FY)
15.47
EPS (TTM)
$-0.75

Price and trading

Previous close
7.00
Open
6.89
Day range
6.47 – 7.14
52-week range
3.46 – 7.83
52-week change
+45.25%
Beta
—
Volume
554.32K

Dividends and events

Annual dividend
None
Next earnings date
Nov 10, 2026

Additional statistics

Market Cap
517.88M
Forward Pe
-5.17
Eps
-0.75
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
7.83
Week52 Low
3.46
Avg Volume
420.19K
Shares Outstanding
78.70M
Ma50
6.01
Ma200
4.71
Earnings Date
Nov 10, 2026
Pct From52w High
-15.91%
Pct From52w Low
90.17%

Related